24.06.2024 08:07:05 - dpa-AFX: *GSK: EMA ACCEPTS JEMPERLI+ CHEMOTHERAPY APPLICATION FOR REVIEW TO EXPAND USE FOR PATIENTS WITH ENDOMETRIAL CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GSK PLC LS-,3125 A3DMB5 Frankfurt 17,605 02.07.24 21:49:52 -0,100 -0,56% 17,590 17,895 17,645 17,605

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH